应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02190 归创通桥-B
休市中 08-23 16:08:27
10.600
-0.340
-3.11%
最高
10.820
最低
10.500
成交量
28.15万
今开
10.700
昨收
10.940
日振幅
2.93%
总市值
34.17亿
流通市值
34.17亿
总股本
3.22亿
成交额
301.30万
换手率
0.09%
流通股本
3.22亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
归创通桥-B(02190)8月23日耗资53.395万港元回购5万股
智通财经 · 08-23 20:57
归创通桥-B(02190)8月23日耗资53.395万港元回购5万股
归创通桥-B午后涨逾6% 中期营收同比增长59%达到3.66亿元
新浪港股 · 08-21
归创通桥-B午后涨逾6% 中期营收同比增长59%达到3.66亿元
异动解读 | 归创通桥-B(02190)中报业绩大增助力股价大涨5%
异动解读 · 08-21
异动解读 | 归创通桥-B(02190)中报业绩大增助力股价大涨5%
港股异动 | 归创通桥-B(02190)涨超5% 公司首次实现净盈利 海外市场业务持续发力
智通财经 · 08-21
港股异动 | 归创通桥-B(02190)涨超5% 公司首次实现净盈利 海外市场业务持续发力
归创通桥-B(02190)上涨5.53%,报11.06元/股
金融界 · 08-21
归创通桥-B(02190)上涨5.53%,报11.06元/股
归创通桥-B盘中异动 大幅拉升5.53%
自选股智能写手 · 08-21
归创通桥-B盘中异动 大幅拉升5.53%
归创通桥-B(02190)股价上升5.534%,现价港币$11.06
阿斯达克财经 · 08-21
归创通桥-B(02190)股价上升5.534%,现价港币$11.06
归创通桥2024年中期业绩:营收同比增长59%达到3.66亿元,首次实现净盈利
格隆汇 · 08-20
归创通桥2024年中期业绩:营收同比增长59%达到3.66亿元,首次实现净盈利
归创通桥-B(02190)公布中期业绩 经调整溢利为7817.1万元 同比扭亏为盈
智通财经 · 08-20
归创通桥-B(02190)公布中期业绩 经调整溢利为7817.1万元 同比扭亏为盈
《业绩》归创通桥(02190.HK)半年亏转盈赚6,886.5万人币
阿斯达克财经 · 08-20
《业绩》归创通桥(02190.HK)半年亏转盈赚6,886.5万人币
归创通桥-B08月20日主力资金流入47万元 连续3日加仓
自选股智能写手 · 08-20
归创通桥-B08月20日主力资金流入47万元 连续3日加仓
归创通桥-B盘中异动 早盘股价大跌6.85%
自选股智能写手 · 08-12
归创通桥-B盘中异动 早盘股价大跌6.85%
归创通桥-B(02190)下跌5.78%,报9.46元/股
金融界 · 08-05
归创通桥-B(02190)下跌5.78%,报9.46元/股
归创通桥-B盘中异动 下午盘急速下挫5.37%报9.501港元
自选股智能写手 · 08-05
归创通桥-B盘中异动 下午盘急速下挫5.37%报9.501港元
归创通桥-B(02190)神经、外周介入龙头,业绩持续快速增长
国元证券(香港) · 07-31
归创通桥-B(02190)神经、外周介入龙头,业绩持续快速增长
归创通桥-B7月31日注销221.9万股已购回股份
新浪港股 · 07-31
归创通桥-B7月31日注销221.9万股已购回股份
归创通桥-B(02190)7月31日注销221.9万股已购回股份
智通财经 · 07-31
归创通桥-B(02190)7月31日注销221.9万股已购回股份
【归创通桥-B(02190.HK)7月31日注销221.9万股已购回股份】智通财经APP讯,归创通桥-B(02190.HK)发布公告,于2024年7月31日该公司注销221.
智通财经 · 07-31
【归创通桥-B(02190.HK)7月31日注销221.9万股已购回股份】智通财经APP讯,归创通桥-B(02190.HK)发布公告,于2024年7月31日该公司注销221.
智通港股早知道 | 港交所解答受制裁企业能否上市 安能物流(09956)发盈喜
智通财经 · 07-30
智通港股早知道 | 港交所解答受制裁企业能否上市 安能物流(09956)发盈喜
归创通桥-B(02190)预喜:上半年盈利不少于5000万元 同比扭亏为盈
智通财经 · 07-29
归创通桥-B(02190)预喜:上半年盈利不少于5000万元 同比扭亏为盈
加载更多
公司概况
公司名称:
归创通桥-B
所属市场:
SEHK
上市日期:
--
主营业务:
归创通桥医疗科技股份有限公司(原名:浙江归创医疗器械有限公司),是一家主要从事神经和外周血管介入医疗器械产品研发的中国公司。该公司主要产品包括蛟龙颅内取栓支架和Ultrafree药物洗脱PTA球囊扩张导管(Ultrafree DCB)。该公司产品销往国内外市场。
发行价格:
--
{"stockData":{"symbol":"02190","market":"HK","secType":"STK","nameCN":"归创通桥-B","latestPrice":10.6,"timestamp":1724400507029,"preClose":10.94,"halted":0,"volume":281500,"delay":0,"floatShares":322400744,"shares":322400744,"eps":-0.26247567,"marketStatus":"休市中","marketStatusCode":7,"change":-0.34,"latestTime":"08-23 16:08:27","open":10.7,"high":10.82,"low":10.5,"amount":3013040,"amplitude":0.02925,"askPrice":10.68,"askSize":1000,"bidPrice":10.6,"bidSize":500,"shortable":0,"etf":0,"ttmEps":0.08622730325970858,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724635800000},"adr":0,"listingDate":1625414400000,"adjPreClose":10.94,"openAndCloseTimeList":[[1724376600000,1724385600000],[1724389200000,1724400000000]],"volumeRatio":1.526572667533297,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02190","defaultTab":"news","newsList":[{"id":"2461596794","title":"归创通桥-B(02190)8月23日耗资53.395万港元回购5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2461596794","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461596794?lang=zh_cn&edition=full","pubTime":"2024-08-23 20:57","pubTimestamp":1724417842,"startTime":"0","endTime":"0","summary":"智通财经APP讯,归创通桥-B(02190)公布,2024年8月23日耗资53.395万港元回购5万股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1169851.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","02190","BK1583","BK1574","BK1100"],"gpt_icon":0},{"id":"2461689698","title":"归创通桥-B午后涨逾6% 中期营收同比增长59%达到3.66亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461689698","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461689698?lang=zh_cn&edition=full","pubTime":"2024-08-21 13:11","pubTimestamp":1724217060,"startTime":"0","endTime":"0","summary":" 归创通桥-B午后上涨5.73%,现报11.08港元,成交额213.75万港元。 归创通桥公布2024年中期业绩,收入约3.66亿元,同比增长59%;毛利约2.61亿元,同比增长52.9%;实现净利润0.69亿元。另外,上半年,公司海外市场业务发展迅速,实现营业收入1149万元人民币,同比增长84.2%。在国产替代的大背景下,未来3年有望保持目前的快速增长。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-08-21/doc-inckkqsn4665404.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-08-21/doc-inckkqsn4665404.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02190"],"gpt_icon":0},{"id":"1131925363","title":"异动解读 | 归创通桥-B(02190)中报业绩大增助力股价大涨5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131925363","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131925363?lang=zh_cn&edition=full","pubTime":"2024-08-21 11:52","pubTimestamp":1724212347,"startTime":"0","endTime":"0","summary":"8月21日,归创通桥-B(02190)盘中股价大涨5.15%,截至中午收盘报11.06元/股,成交180.6万元。\n\n公司2024财年中期业绩显示,营业总收入3.66亿元、净利润6886.5万元,同比增长293.91%,每股收益0.2125元。业绩大幅增长成为当日股价上涨的主要推手。\n\n作为中国领先的神经和外周血管介入医疗器械企业,归创通桥-B产品包括治疗急性缺血性脑卒中、颅内动脉瘤等疾病领域。随着公司持续创新及营收利润的增长,未来前景值得期待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190"],"gpt_icon":0},{"id":"2461867033","title":"港股异动 | 归创通桥-B(02190)涨超5% 公司首次实现净盈利 海外市场业务持续发力","url":"https://stock-news.laohu8.com/highlight/detail?id=2461867033","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461867033?lang=zh_cn&edition=full","pubTime":"2024-08-21 11:45","pubTimestamp":1724211914,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,归创通桥-B(02190)涨超5%,截至发稿,涨5.53%,报11.06港元,成交额182.24万港元。消息面上,归创通桥公布2024年中期业绩,收入约3.66亿元,同比增长59%;毛利约2.61亿元,同比增长52.9%;实现净利润0.69亿元。另外,上半年,公司海外市场业务发展迅速,实现营业收入1149万元人民币,同比增长84.2%。国元国际指出,公司是国内神经和外周血管介入龙头,产品管线丰富,产品力不断提升,生产成本进一步优化,公司也实现了盈利。在国产替代的大背景下,未来3年有望保持目前的快速增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1167478.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","BK1574","BK1583","02190","BK1587"],"gpt_icon":0},{"id":"2461867411","title":"归创通桥-B(02190)上涨5.53%,报11.06元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2461867411","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461867411?lang=zh_cn&edition=full","pubTime":"2024-08-21 11:42","pubTimestamp":1724211728,"startTime":"0","endTime":"0","summary":"8月21日,归创通桥-B(02190)盘中上涨5.53%,截至11:42,报11.06元/股,成交180.6万元。归创通桥医疗科技股份有限公司是中国神经和外周血管介入医疗器械市场的领导者,主要为中国及海外的医生和患者提供治疗及应对神经和外周血管疾病的先进医疗器械。公司的主要治疗领域包括急性缺血性脑卒中、颅内动脉瘤、颈动脉狭窄、外周动脉和静脉疾病以及透析相关疾病。截至2024年中报,归创通桥-B营业总收入3.66亿元、净利润6886.5万元。8月20日,2024财年中报归属股东应占溢利6887万人民币,同比增长293.91%,基本每股收益0.2125人民币。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/08/21114242552576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02190","BK1587","BK1574","BK1583","BK1100"],"gpt_icon":0},{"id":"2461860837","title":"归创通桥-B盘中异动 大幅拉升5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461860837","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461860837?lang=zh_cn&edition=full","pubTime":"2024-08-21 11:42","pubTimestamp":1724211725,"startTime":"0","endTime":"0","summary":"2024年08月21日临近午盘11时42分,归创通桥-B股票出现异动,股价快速拉升5.53%。归创通桥-B股票所在的医疗设备及用品行业中,整体跌幅为0.02%。其相关个股中,归创通桥-B、HKE HOLDINGS、威高股份涨幅较大,振幅较大的相关个股有HKE HOLDINGS、巨星医疗控股、威高股份,振幅分别为12.04%、8.62%、6.63%。消息层面,截至11时42分,归创通桥-B股票正面舆情新闻比例50%。2024年上半年,公司营业收入达到3.66亿元,同比增幅59.0%;同期实现净利润0.69亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082111420698e35a22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082111420698e35a22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1583","BK1574","02190","BK1100"],"gpt_icon":0},{"id":"2461860691","title":"归创通桥-B(02190)股价上升5.534%,现价港币$11.06","url":"https://stock-news.laohu8.com/highlight/detail?id=2461860691","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461860691?lang=zh_cn&edition=full","pubTime":"2024-08-21 11:42","pubTimestamp":1724211720,"startTime":"0","endTime":"0","summary":"[上升股]归创通桥-B(02190) 股价在上午11:42比前收市价上升5.534%,现股价为港币$11.06。至目前为止,今日最高价为$11.06,而最低价为$10.5。总成交量为17万股,总成交金额为港币$180.596万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2408211191/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1587","02190","BK1100","BK1583","BK1574"],"gpt_icon":0},{"id":"2460027040","title":"归创通桥2024年中期业绩:营收同比增长59%达到3.66亿元,首次实现净盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=2460027040","media":"格隆汇","labels":["viewpoints"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460027040?lang=zh_cn&edition=full","pubTime":"2024-08-20 17:17","pubTimestamp":1724145443,"startTime":"0","endTime":"0","summary":"8月20日,归创通桥医疗科技股份有限公司发布2024年中期业绩公告。2024年上半年,公司营业收入达到3.66亿元,同比增幅59.0%;同期实现净利润0.69亿元。面对复杂多变的市场环境,归创通桥营收持续增长并首次实现净利润盈利,标志公司规模效应显现,已迈过盈亏平衡点,步入稳健发展的新阶段。海外市场业务持续发力 惠及更多全球患者上半年,公司海外市场业务发展迅速,实现营业收入1149万元人民币,同比增长84.2%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820171723ab5e95ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820171723ab5e95ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"viewpoints","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02190"],"gpt_icon":0},{"id":"2460224840","title":"归创通桥-B(02190)公布中期业绩 经调整溢利为7817.1万元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2460224840","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460224840?lang=zh_cn&edition=full","pubTime":"2024-08-20 16:58","pubTimestamp":1724144281,"startTime":"0","endTime":"0","summary":"智通财经APP讯,归创通桥-B 公布2024年中期业绩,收入约3.66亿元,同比增长59%;毛利约2.61亿元,同比增长52.9%;期内溢利6886.5万元,去年同期亏损3551.4万元;经调整溢利为7817.1万元,去年同期经调整净亏损为552.2万元;每股基本盈利0.2125元。公告称,收入的显著增长主要归因于神经血管和外周血管介入器械分部的销售额高速增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1166978.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1574","BK1100","BK1587","02190"],"gpt_icon":0},{"id":"2460022674","title":"《业绩》归创通桥(02190.HK)半年亏转盈赚6,886.5万人币","url":"https://stock-news.laohu8.com/highlight/detail?id=2460022674","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460022674?lang=zh_cn&edition=full","pubTime":"2024-08-20 16:53","pubTimestamp":1724143980,"startTime":"0","endTime":"0","summary":"归创通桥-B(02190.HK) 公布截至今年6月底止中期业绩,营业额3.66亿元人民币(下同),按年升59%。亏转盈赚6,886.5万元,上年同期蚀3,551.4万元;每股盈利21.25分。不派息。(ha/da)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2024/03/21末期业绩无派息2023/08/23中期业绩无派息2023/03/29末期业绩无派息 2022/08/15中期业绩无派息 AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220725164330597_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220725164330597_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1373242/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02190","BK1583","BK1574","BK1587","BK1100"],"gpt_icon":0},{"id":"2460502963","title":"归创通桥-B08月20日主力资金流入47万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2460502963","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460502963?lang=zh_cn&edition=full","pubTime":"2024-08-20 16:15","pubTimestamp":1724141710,"startTime":"0","endTime":"0","summary":"08月20日, 归创通桥-B股价跌0.19%,报收10.48元,成交金额68万元,换手率0.02%,振幅2.29%,量比0.49。归创通桥-B今日主力资金净流入47万元,连续3日净流入,上一交易日主力净流入36万元,今日环比增加30.56%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为75.00%,平均涨幅为7.21%。该股近5个交易日上涨4.80%,主力资金累计净流入106万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入106万元,其中净流入天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082016152095a9e6e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082016152095a9e6e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","02190","BK1574","BK1583","BK1100"],"gpt_icon":0},{"id":"2458643727","title":"归创通桥-B盘中异动 早盘股价大跌6.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458643727","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458643727?lang=zh_cn&edition=full","pubTime":"2024-08-12 09:30","pubTimestamp":1723426207,"startTime":"0","endTime":"0","summary":"2024年08月12日早盘09时30分,归创通桥-B股票出现波动,股价大幅跳水6.85%。截至发稿,该股报9.501港元/股,成交量500股,换手率0.00%,振幅0.00%。机构评级方面,在所有2家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。其相关个股中,心通医疗-B、微创医疗、智云健康涨幅较大,振幅较大的相关个股有康基医疗、沛嘉医疗-B、智云健康,振幅分别为0.00%、0.00%、0.00%。该公司产品销往国内外市场。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081209300798e34d79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081209300798e34d79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","02190","BK1587","BK1574","BK1100"],"gpt_icon":0},{"id":"2457971509","title":"归创通桥-B(02190)下跌5.78%,报9.46元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2457971509","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457971509?lang=zh_cn&edition=full","pubTime":"2024-08-05 14:29","pubTimestamp":1722839340,"startTime":"0","endTime":"0","summary":"8月5日,归创通桥-B(02190)盘中下跌5.78%,截至14:29,报9.46元/股,成交298.5万元。归创通桥医疗科技股份有限公司是中国神经和外周血管介入医疗器械市场的领导者,主要为中国及海外的医生和患者提供治疗及应对神经和外周血管疾病的先进医疗器械。公司的主要治疗领域包括急性缺血性脑卒中、颅内动脉瘤、颈动脉狭窄、外周动脉和静脉疾病以及透析相关疾病。截至2023年年报,归创通桥-B营业总收入5.28亿元、净利润-7873.4万元。8月20日,归创通桥-B将披露2024财年中报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/08/05142942044954.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1587","02190","BK1100","BK1583","BK1574"],"gpt_icon":0},{"id":"2457716736","title":"归创通桥-B盘中异动 下午盘急速下挫5.37%报9.501港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457716736","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457716736?lang=zh_cn&edition=full","pubTime":"2024-08-05 14:28","pubTimestamp":1722839337,"startTime":"0","endTime":"0","summary":"2024年08月05日下午盘14时28分,归创通桥-B股票出现异动,股价快速跳水5.37%。截至发稿,该股报9.501港元/股,成交量30.55万股,换手率0.09%,振幅4.98%。资金方面,该股资金流入64.0505万港元,流出208.971万港元。归创通桥-B股票所在的医疗设备及用品行业中,整体跌幅为0.21%。其相关个股中,紫元元、加和国际控股、康沣生物-B涨幅较大,振幅较大的相关个股有百心安-B、微创机器人-B、中国卫生集团,振幅分别为12.88%、11.19%、10.29%。该公司产品销往国内外市场。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805142858aefd3513&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805142858aefd3513&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1587","02190","BK1583","BK1100"],"gpt_icon":0},{"id":"2455975906","title":"归创通桥-B(02190)神经、外周介入龙头,业绩持续快速增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2455975906","media":"国元证券(香港)","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455975906?lang=zh_cn&edition=full","pubTime":"2024-07-31 14:14","pubTimestamp":1722406482,"startTime":"0","endTime":"0","summary":"事件:公司盈利预告:2024上半年营业收入不少于3.6亿,与2023年同期相比,收入从人民币2.3亿元增加了不少于56.5%。公司业绩是持续增长,2023年营业收入为人民币5.28亿元,同比上升57.6%,归母净利润为-0.79亿元,同比增长30.7%。2023年,公司来自中国以外地区的收入达到了1.43亿元人民币,比2022年增长了83.1%。在河南省的带量采购中,公司几乎所有竞标的神经血管介入产品中标,产品入院率接近100%。同时,凤颅内动脉瘤栓塞弹簧圈的市场份额也快速增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407311430359f00dad6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407311430359f00dad6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","BK1100","BK1587","02190"],"gpt_icon":0},{"id":"2455925018","title":"归创通桥-B7月31日注销221.9万股已购回股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2455925018","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455925018?lang=zh_cn&edition=full","pubTime":"2024-07-31 12:17","pubTimestamp":1722399420,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 归创通桥-B(02190)发布公告,于2024年7月31日该公司注销221.9万股已购回股份。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-07-31/doc-incfyxci9214661.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-07-31/doc-incfyxci9214661.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02190","BK1583","BK1574","BK1587","BK1100"],"gpt_icon":0},{"id":"2455925102","title":"归创通桥-B(02190)7月31日注销221.9万股已购回股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2455925102","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455925102?lang=zh_cn&edition=full","pubTime":"2024-07-31 12:14","pubTimestamp":1722399277,"startTime":"0","endTime":"0","summary":"智通财经APP讯,归创通桥-B(02190)发布公告,于2024年7月31日该公司注销221.9万股已购回股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1157841.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02190","BK1574","BK1100","BK1587","BK1583"],"gpt_icon":0},{"id":"2455251419","title":"【归创通桥-B(02190.HK)7月31日注销221.9万股已购回股份】智通财经APP讯,归创通桥-B(02190.HK)发布公告,于2024年7月31日该公司注销221.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455251419","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455251419?lang=zh_cn&edition=full","pubTime":"2024-07-31 12:14","pubTimestamp":1722399277,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1100","BK1587","BK1583","BK1574","02190"],"gpt_icon":0},{"id":"2455457496","title":"智通港股早知道 | 港交所解答受制裁企业能否上市 安能物流(09956)发盈喜","url":"https://stock-news.laohu8.com/highlight/detail?id=2455457496","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455457496?lang=zh_cn&edition=full","pubTime":"2024-07-30 07:40","pubTimestamp":1722296443,"startTime":"0","endTime":"0","summary":"日前,港交所上市科IPO审查联席主管刘颖表示,18C章为特专科技公司所设,若IPO申请人存在被制裁风险,需要一事一议,港交所将逐一进行具体评估。而针对从内地撤退转赴香港的IPO企业,审查时会重点关注此前被问询的问题是否已经解决。截至目前,中药材市场价格并未出现任何放缓或“降温”的迹象。此外,6月行业集中度环比提升,头部快递市场份额整体保持稳定。涉及港股万洲国际。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1157158.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1171","03808","SG9999011746.SGD","BK1141","LU1046422090.SGD","LU0572944931.SGD","BK1220","BK1257","02190","03606","LU0541501648.USD","LU0052750758.USD","09956","BK1548","SG9999001051.SGD","01810","BK1100","LU2045819591.USD","BK1583","LU0320764599.SGD","YANG","LU0287142896.SGD","00288","HSCEI","LU0456827905.SGD","HSTECH","BK1237","BK1543","SGXZ90724238.SGD","SG9999001226.SGD","BK1603","LU0708995583.HKD","SG9999001069.SGD","LU0327786744.USD","LU2125910500.SGD","LU0702159699.USD","BK1574","BK1509","IE0034224299.USD","02359","BK1576","BK1144","LU1166156734.SGD","BK1594","BK1521","LU0173614495.USD","LU0541502299.USD","BK1587","LU0051755006.USD","BK1554"],"gpt_icon":1},{"id":"2455632683","title":"归创通桥-B(02190)预喜:上半年盈利不少于5000万元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2455632683","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455632683?lang=zh_cn&edition=full","pubTime":"2024-07-29 17:56","pubTimestamp":1722246963,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,7月29日,归创通桥-B发布公告称,集团预期截至2024年6月30日止六个月实现收入不少于人民币3.6亿元,同比增加不少于56.5%。值得注意的是,集团亦预期录得公司权益持有人应占溢利净额不少于人民币5000万元,同比扭亏为盈。此前,归创通桥自主研发的ZYLOX Unicorn血管缝合器获国家药品监督管理局批准上市,标志着国产品牌已经打破进口品牌在血管穿刺点缝合解决方案的市场垄断地位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1156889.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02190","BK1583","BK1100","BK1587","BK1574"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zyloxmedical.com","stockEarnings":[{"period":"1week","weight":0.0433},{"period":"1month","weight":-0.0239},{"period":"3month","weight":0.0192},{"period":"6month","weight":0.0579},{"period":"1year","weight":0.2354},{"period":"ytd","weight":-0.1479}],"compareEarnings":[{"period":"1week","weight":0.0104},{"period":"1month","weight":0.0174},{"period":"3month","weight":-0.0536},{"period":"6month","weight":0.053},{"period":"1year","weight":-0.0329},{"period":"ytd","weight":0.0331}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"归创通桥医疗科技股份有限公司(原名:浙江归创医疗器械有限公司),是一家主要从事神经和外周血管介入医疗器械产品研发的中国公司。该公司主要产品包括蛟龙颅内取栓支架和Ultrafree药物洗脱PTA球囊扩张导管(Ultrafree DCB)。该公司产品销往国内外市场。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.06758},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.161655},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.081343},{"month":4,"riseRate":0.666667,"avgChangeRate":0.102094},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.055316},{"month":6,"riseRate":0.666667,"avgChangeRate":0.085175},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.09818},{"month":8,"riseRate":0.5,"avgChangeRate":-0.064266},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.046366},{"month":10,"riseRate":0.333333,"avgChangeRate":0.000643},{"month":11,"riseRate":0.666667,"avgChangeRate":0.048494},{"month":12,"riseRate":0.666667,"avgChangeRate":0.062139}],"exchange":"SEHK","name":"归创通桥-B","nameEN":"ZYLOXTB-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"归创通桥-B(02190)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供归创通桥-B(02190)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"归创通桥-B,02190,归创通桥-B股票,归创通桥-B股票老虎,归创通桥-B股票老虎国际,归创通桥-B行情,归创通桥-B股票行情,归创通桥-B股价,归创通桥-B股市,归创通桥-B股票价格,归创通桥-B股票交易,归创通桥-B股票购买,归创通桥-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"归创通桥-B(02190)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供归创通桥-B(02190)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}